Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 90, Issue 6, 2000, Pages 713-715

  Calista, Donato ^a  

^a BUFALINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOSINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHONIC ACID DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CASE REPORT; GINGIVA DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PAPILLOMA VIRUS; VIROLOGY; VIRUS INCLUSION; VIRUS INFECTION;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIVIRAL AGENTS; CYTOSINE; GINGIVAL DISEASES; HIV INFECTIONS; HUMANS; INCLUSION BODIES, VIRAL; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHONIC ACIDS;

EID: 0034571298     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2000.110413     Document Type: Article

References (13)

1. Scully C, Cox MF, Prime SS, Maitland NJ. Papillomavirus: the current status in relation to oral disease. Oral Surg Oral Med Oral Pathol 1988;65:526-32.
2. Sterling JC, Kurtz JB. Human papillomavirus. In: Rook, Wilkinson, Ebling, editors. Textbook of dermatology. 6th ed. Oxford (England): Blackwell Science; 1998. p. 1040-5.
3. Shroyer KR, Greer Ro. Detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction in premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol 1991;71:708-13.
4. De Clercq E. Therapeutic potential of cidofovir for the treatment of DNA virus infection. Verh K Acad Geneeskd Belg 1996;58:19-49.
5. Zabawski EJ, Cockerell CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects. J Am Acad Dermatol 1998;39:741-5.
6. Lalezari JP, Stagg J, Kuppermann BD, Holland GN, Krame F, Ives DV, et al. Intravenous cidofovir for peripheral cytomegalovirus infection in patients with AIDS. Ann Intern Med 1997;126:257-63.
7. Taskintuna I, Rahhal FM, Rao NA, Wiley CA, Mueller AJ, Banker AS, et al. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrom (AIDS). Ophthalmology 1997;104:1827-36.
8. Calista D, Boschini A, Romio S, Landi G. Cidofovir: un promettente trattomento topico per le dermatosi virali in pazienti con AIDS. G Ital Dermatol Venereol. 2000;135:393-7.
9. Lalezari J, Jaffe HS, Schacter T, Feinberg J, Gathe J, Lee S, et al. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis 1997;176:892-8.
10. Simon GL. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir. Clin Infect Dis 1998;26:1233.
11. Meadows KP, Tyring SK, Pavia AT, Rallis TM. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 1997;133:987-90.
12. Snoeck R, Van Ranst M, Andrei G, Le Clercq E, De Wit S, Poncin M, et al. Treatment of anogenital papillomavirus infection with an acyclic nucleoside phosphinate analogue. New Engl J Med 1995;333:943-4.
13. Zabawski EJ, Sande B, Goetz D, Naylor M, Cockerell CJ. Treatment of verruca vulgaris with topical cidofovir (letter). JAMA 1997;278:1236.